Skip to main content
Top
Published in: Nutrition Journal 1/2009

Open Access 01-12-2009 | Short report

Differential susceptibility to obesity between male, female and ovariectomized female mice

Authors: Jina Hong, Renee E Stubbins, Rebekah R Smith, Alison E Harvey, Nomelí P Núñez

Published in: Nutrition Journal | Issue 1/2009

Login to get access

Abstract

Background

The prevalence of obesity has increased dramatically. A direct comparison in the predisposition to obesity between males, premenopausal females, and postmenopausal females with various caloric intakes has not been made. To determine the effects of sex and ovarian hormones on the susceptibility to obesity, we conducted laboratory studies with mice. To eliminate confounders that can alter body weight gain, such as age and food consumption; we used mice with the same age and controlled the amount of calories they consumed.

Methods

We determined sex-specific susceptibility to obesity between male, non-ovariectomized female, and ovariectomized female mice. To compare susceptibility to gaining body weight between males and females, animals from each sex were exposed to either a 30% calorie-restricted, low-fat (5% fat), or high-fat (35% fat) diet regimen. To establish the role of ovarian hormones in weight gain, the ovaries were surgically removed from additional female mice, and then were exposed to the diets described above. Percent body fat and percent lean mass in the mice were determined by dual energy x-ray absorptiometry (DEXA).

Results

In all three diet categories, male mice had a greater propensity of gaining body weight than female mice. However, ovariectomy eliminated the protection of female mice to gaining weight; in fact, ovariectomized female mice mimicked male mice in their susceptibility to weight gain. In summary, results show that male mice are more likely to become obese than female mice and that the protection against obesity in female mice is eliminated by ovariectomy.

Conclusion

Understanding metabolic differences between males and females may allow the discovery of better preventive and treatment strategies for diseases associated with body weight such as cancer and cardiovascular disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK: Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008, 16 (10): 2323-2330. 10.1038/oby.2008.351.CrossRefPubMed Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK: Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008, 16 (10): 2323-2330. 10.1038/oby.2008.351.CrossRefPubMed
2.
go back to reference Power ML, Schulkin J: Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition. 2008, 99: 931-40. 10.1017/S0007114507853347.CrossRefPubMed Power ML, Schulkin J: Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition. 2008, 99: 931-40. 10.1017/S0007114507853347.CrossRefPubMed
3.
go back to reference Yakar S, Nunez NP, Pennisi P, Brodt P, Sun H, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N, Stannard B, East-Palmer J, Smith NC, Perkins SN, Fuchs-Young R, Barrett JC, Hursting SD, LeRoith D: Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology. 2006, 147: 5826-34. 10.1210/en.2006-0311.CrossRefPubMed Yakar S, Nunez NP, Pennisi P, Brodt P, Sun H, Fallavollita L, Zhao H, Scavo L, Novosyadlyy R, Kurshan N, Stannard B, East-Palmer J, Smith NC, Perkins SN, Fuchs-Young R, Barrett JC, Hursting SD, LeRoith D: Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology. 2006, 147: 5826-34. 10.1210/en.2006-0311.CrossRefPubMed
4.
go back to reference Catala-Niell A, Estrany ME, Proenza AM, Gianotti M, Llado I: Skeletal muscle and liver oxidative metabolism in response to a voluntary isocaloric intake of a high fat diet in male and female rats. Cellular Physiology and Biochemistry. 2008, 22: 327-36. 10.1159/000149811.CrossRefPubMed Catala-Niell A, Estrany ME, Proenza AM, Gianotti M, Llado I: Skeletal muscle and liver oxidative metabolism in response to a voluntary isocaloric intake of a high fat diet in male and female rats. Cellular Physiology and Biochemistry. 2008, 22: 327-36. 10.1159/000149811.CrossRefPubMed
5.
go back to reference Nunez NP, Perkins SN, Smith NC, Berrigan D, Berendes DM, Varticovski L, Barrett JC, Hursting SD: Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutrition Cancer. 2008, 60 (4): 534-41. 10.1080/01635580801966195.CrossRefPubMed Nunez NP, Perkins SN, Smith NC, Berrigan D, Berendes DM, Varticovski L, Barrett JC, Hursting SD: Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutrition Cancer. 2008, 60 (4): 534-41. 10.1080/01635580801966195.CrossRefPubMed
6.
go back to reference Núñez NP, Carpenter CL, Perkins SN, Berrigan D, Jaque SV, Ingles SA, Bernstein L, Forman MR, Barrett JC, Hursting SD: Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring). 2007, 15: 1980-7. 10.1038/oby.2007.236.CrossRef Núñez NP, Carpenter CL, Perkins SN, Berrigan D, Jaque SV, Ingles SA, Bernstein L, Forman MR, Barrett JC, Hursting SD: Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity (Silver Spring). 2007, 15: 1980-7. 10.1038/oby.2007.236.CrossRef
7.
go back to reference Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317: 121-4. 10.1126/science.1140485.CrossRefPubMed Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317: 121-4. 10.1126/science.1140485.CrossRefPubMed
8.
go back to reference Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006, 444: 337-42. 10.1038/nature05354.CrossRefPubMed Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA: Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006, 444: 337-42. 10.1038/nature05354.CrossRefPubMed
9.
go back to reference Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007, 450: 712-6. 10.1038/nature06261.CrossRefPubMedPubMedCentral Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007, 450: 712-6. 10.1038/nature06261.CrossRefPubMedPubMedCentral
10.
go back to reference Case A, Paxson C: Sex differences in morbidity and mortality. Demography. 2005, 42: 189-214. 10.1353/dem.2005.0011.CrossRefPubMed Case A, Paxson C: Sex differences in morbidity and mortality. Demography. 2005, 42: 189-214. 10.1353/dem.2005.0011.CrossRefPubMed
11.
go back to reference American Cancer Society: Cancer Facts & Figures 2007. 2007, American Cancer Society American Cancer Society: Cancer Facts & Figures 2007. 2007, American Cancer Society
12.
go back to reference National Heart, Lung, and Blood Institute: Morbidity & Mortality: 2007 Chart on Cardiovascular, Lung, and Blood Diseases. NILBI. 2007 National Heart, Lung, and Blood Institute: Morbidity & Mortality: 2007 Chart on Cardiovascular, Lung, and Blood Diseases. NILBI. 2007
Metadata
Title
Differential susceptibility to obesity between male, female and ovariectomized female mice
Authors
Jina Hong
Renee E Stubbins
Rebekah R Smith
Alison E Harvey
Nomelí P Núñez
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2009
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-8-11

Other articles of this Issue 1/2009

Nutrition Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.